Up next

Autoplay

Zev Wainberg, MD, considers regorafenib in locally advanced biliary tract cancer

5 Views • 07/09/23
Share
Embed
administrator
administrator
Subscribers
0

Dr. Wainberg, Co-Director, UCLA Gastro-Intestinal Oncology Program, Medical Director, UCLA Colorectal Cancer Center, Assistant Professor of Medicine, Division of Hematology Oncology, David Geffen School of Medicine at UCLA, considers the Phase 2 REACHIN study investigating regorafenib in locally advanced biliary tract cancer

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay